LifeVantage Corporation
corporate_fare Company Profile
LifeVantage Corporation (NASDAQ:LFVN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for LFVN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for LFVN spans 10-Q, 8-K, 10-K, 4.
Recent high-impact activity:
- LifeVantage Swings to $196K Q1 Loss as Revenue Falls 22% to $37.1M
- LifeVantage Q1 Revenue Slides to $37.1M as Sales Slump Persists
- LifeVantage Q4 Revenue Falls 23% as Active Accounts Shrink 21%; FY27 Guidance Withheld
- LifeVantage FY2026 10-K: Revenue Falls 20%, Active Accounts Drop 21%, New CEO and $60M Buyback Authorized
- LifeVantage Q4 Revenue Plunges 23% as Active Accounts Shrink 21%
Financial Snapshot
Short Interest & Short Volume
42.11 days to coverFINRA reported short interest of 906,622 shares in LFVN as of the October 30, 2026 settlement, a 7.1% decrease from the prior period — about 42.1 days to cover at its recent average daily volume. On November 20, 2026, 40.5% of LFVN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.